Delcath Systems Share Price (NASDAQ: DCTH)

$10.34

▲

-0.13

(-1.24%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Delcath Systems Stock chart to analyse performance

Delcath Systems stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$10.33
Today's High:$10.52
$10.34
0.1%
Downside
Day's Volatility :1.76%
Upside
1.66%
52 Weeks Low:$7.45
52 Weeks High:$18.23
$10.34
27.95%
Downside
52 Weeks Volatility :59.13%
Upside
43.28%

Delcath Systems Stock Returns

Period	Delcath Systems Inc	Index (Russel 2000)
3 Months	-42.93%	0.0%
6 Months	-36.9%	0.0%
1 Year	37.73%	0.0%
3 Years	129.56%	-12.4%

Delcath Systems Inc Key Stats

Check Delcath Systems key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$10.47
Open	$10.5
Today's High	$10.515
Today's Low	$10.33
Market Capitalization	$366.3M
Today's Volume	$434.3K
52 Week High	$18.23
52 Week Low	$7.45
Revenue TTM	$70.2M
EBITDA	$5.2M
Earnings Per Share (EPS)	$0.09
PE Ratio	116.33
Profit Margin	3.18%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	3.57%

Stock Returns calculator for Delcath Systems Stock including INR - Dollar returns

The Delcath Systems stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Delcath Systems investment value today

Current value as on today

₹1,42,077

Returns

₹42,077

(+42.08%)

Returns from Delcath Systems Stock

₹37,867 (+37.87%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Delcath Systems Stock

-19%

Period: Jul 16, 2025 to Aug 15, 2025. Change in 30 Days versus previous period

Search interest for Delcath Systems Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Delcath Systems Inc

Name
Holdings %
Name
Holdings %
Rosalind Advisors, Inc.
8.29%
Vanguard Group Inc
3.99%
Deerfield Management Co
2.32%
Vivo Capital, LLC
2.14%
ExodusPoint Capital Management, LP
2.00%
Susquehanna International Group, LLP
1.59%

Analyst Recommendation on Delcath Systems Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Delcath Systems(by analysts ranked 0 to 5 stars)

Delcath Systems Share Price Target

What analysts predicted

Upside of 135.33%

Target:

$24.33

Current:

$10.34

Delcath Systems share price target is $24.33, a slight Upside of 135.33% compared to current price of $10.34 as per analysts' prediction.

Delcath Systems Stock Insights

Price Movement
In the last 3 months, DCTH stock has moved down by -39.6%
Increasing Revenue
Revenue is up for the last 8 quarters, 434.0K → 24.15M (in $), with an average increase of 37.0% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -3.39M → 2.69M (in $), with an average increase of 239.1% per quarter
DCTH vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 143.7% return, outperforming this stock by 8.9%

Delcath Systems Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.6M	↓ 53.62%
Net Income	$-13.6M	↓ 29.11%
Net Profit Margin	-862.47%	↓ 298.28%

	FY20	Y/Y Change
Revenue	$1.6M	↑ 4.18%
Net Income	$-24.5M	↑ 79.68%
Net Profit Margin	-1.5K%	↓ 625.08%

	FY21	Y/Y Change
Revenue	$3.6M	↑ 115.98%
Net Income	$-26.8M	↑ 9.28%
Net Profit Margin	-752.66%	↑ 734.89%

	FY22	Y/Y Change
Revenue	$2.7M	↓ 23.52%
Net Income	$-39.2M	↑ 46.37%
Net Profit Margin	-1.4K%	↓ 687.69%

	FY23	Y/Y Change
Revenue	$2.1M	↓ 24.05%
Net Income	$-47.7M	↑ 21.74%
Net Profit Margin	-2.3K%	↓ 868.51%

	FY24	Y/Y Change
Revenue	$37.2M	↑ 1701.69%
Net Income	$-26.4M	↓ 44.66%
Net Profit Margin	-70.92%	↑ 2237.94%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$3.1M	↑ 482.37%
Net Income	$-11.1M	↓ 0.22%
Net Profit Margin	-353.97%	↑ 1712.08%

	Q2 FY24	Q/Q Change
Revenue	$7.8M	↑ 147.4%
Net Income	$-13.7M	↑ 23.67%
Net Profit Margin	-176.94%	↑ 177.03%

	Q3 FY24	Q/Q Change
Revenue	$9.6M	↑ 23.1%
Net Income	$1.9M	↓ 113.57%
Net Profit Margin	19.5%	↑ 196.44%

	Q4 FY24	Q/Q Change
Revenue	$15.1M	↑ 57.95%
Net Income	$-3.4M	↓ 282.3%
Net Profit Margin	-22.5%	↓ 42.0%

	Q1 FY25	Q/Q Change
Revenue	$19.8M	↑ 31.02%
Net Income	$1.1M	↓ 131.46%
Net Profit Margin	5.4%	↑ 27.9%

	Q2 FY25	Q/Q Change
Revenue	$24.2M	↑ 22.1%
Net Income	$2.7M	↑ 152.29%
Net Profit Margin	11.16%	↑ 5.76%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$861.0K	↓ 64.1%

	FY20	Y/Y Change
Profit	$1.0M	↑ 16.84%

	FY21	Y/Y Change
Profit	$2.9M	↑ 186.68%

	FY22	Y/Y Change
Profit	$2.0M	↓ 29.51%

	FY23	Y/Y Change
Profit	$1.4M	↓ 29.66%

	FY24	Y/Y Change
Profit	$31.0M	↑ 2069.02%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 583.79%

	Q2 FY24	Q/Q Change
Profit	$6.2M	↑ 179.38%

	Q3 FY24	Q/Q Change
Profit	$9.6M	↑ 53.03%

	Q4 FY24	Q/Q Change
Profit	$13.0M	↑ 35.71%

	Q1 FY25	Q/Q Change
Profit	$16.9M	↑ 30.56%

	Q2 FY25	Q/Q Change
Profit	$20.8M	↑ 23.02%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-23.7M	↑ 60.81%
Investing Cash Flow	$-24.0K	↓ 68.42%
Financing Cash Flow	$30.3M	↑ 128.96%

	FY20	Y/Y Change
Operating Cash Flow	$-22.9M	↓ 3.47%
Investing Cash Flow	$-782.0K	↑ 3158.33%
Financing Cash Flow	$42.4M	↑ 39.76%

	FY21	Y/Y Change
Operating Cash Flow	$-22.6M	↓ 1.15%
Investing Cash Flow	$-143.0K	↓ 81.71%
Financing Cash Flow	$20.8M	↓ 50.84%

	FY22	Y/Y Change
Operating Cash Flow	$-25.0M	↑ 10.38%
Investing Cash Flow	$-209.0K	↑ 46.15%
Financing Cash Flow	$10.1M	↓ 51.29%

	FY23	Y/Y Change
Operating Cash Flow	$-31.3M	↑ 25.25%
Investing Cash Flow	$-19.7M	↑ 9330.14%
Financing Cash Flow	$51.8M	↑ 410.48%

	FY24	Y/Y Change
Operating Cash Flow	$-18.7M	↓ 40.22%
Investing Cash Flow	$-981.0K	↓ 95.02%
Financing Cash Flow	$39.4M	↓ 23.89%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-9.6M	↑ 17.19%
Investing Cash Flow	$4.7M	↓ 123.69%
Financing Cash Flow	$4.0M	↑ 402000.0%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.5M	↓ 53.56%
Investing Cash Flow	$10.3M	↑ 120.69%
Financing Cash Flow	$-2.9M	↓ 170.98%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-3.6M	↓ 18.22%
Investing Cash Flow	$-697.0K	↓ 106.78%
Financing Cash Flow	$-2.1M	↓ 24.95%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-1.0M	↓ 72.36%
Investing Cash Flow	$-15.2M	↑ 2084.79%
Financing Cash Flow	$40.4M	↓ 1985.39%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$2.2M	↓ 318.99%
Investing Cash Flow	$-25.1M	↑ 65.14%
Financing Cash Flow	$3.3M	↓ 91.95%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.3M	↑ 231.05%
Investing Cash Flow	$-415.0K	↓ 98.35%
Financing Cash Flow	$14.6M	↑ 350.02%

Delcath Systems Technicals Summary

Sell

Neutral

Buy

Delcath Systems is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Delcath Systems Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Delcath Systems Inc	-8.75%	-36.9%	37.73%	129.56%	-14.98%
Medtronic Plc	3.88%	8.05%	9.93%	-2.01%	-8.7%
Edwards Lifesciences Corp.	2.7%	3.4%	13.52%	-22.17%	-0.25%
Boston Scientific Corp.	-1.38%	-2.03%	31.9%	143.25%	162.29%
Stryker Corporation	-1.81%	-0.97%	13.01%	72.45%	102.01%
Abbott Laboratories	9.33%	1.21%	18.69%	19.18%	30.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Delcath Systems Inc	116.33	116.33	NA	0.07	0.04	0.04	NA	3.0
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.74	32.74	4.67	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.99	61.99	1.81	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.27	50.27	2.15	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.22	16.22	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Delcath Systems Inc	Buy	$366.3M	-14.98%	116.33	3.18%
Medtronic Plc	Buy	$118.0B	-8.7%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.25%	32.74	72.96%
Boston Scientific Corp.	Buy	$154.3B	162.29%	61.99	13.55%
Stryker Corporation	Buy	$144.7B	102.01%	50.27	12.25%
Abbott Laboratories	Buy	$225.0B	30.82%	16.22	32.43%

About Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.

Organization	Delcath Systems
Employees	96
CEO	Mr. Gerard J. Michel MBA, MS
Industry	Medical Specialties

Key Management of Delcath Systems Inc

Name	Title
Mr. Gerard J. Michel MBA, MS	CEO & Director
Dr. Martha S. Rook Ph.D.	Chief Operating Officer
Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.	Chief Medical Officer
Ms. Sandra Pennell CPA	Chief Financial Officer
Mr. David Hoffman J.D.	General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. Johnny John M.D.	Senior Vice President of Clinical Operations & Medical Affairs
Dr. Michael Brunner M.D.	Senior Vice President of Interventional Oncology

Important FAQs about investing in DCTH Stock from India :

What is Delcath Systems share price today?

Delcath Systems share price today is $10.34 as on August 16, 2025 at 1:29 AM IST at the close of the market. Delcath Systems share today touched a day high of $10.52 and a low of $10.33.

What is the 52 week high and 52 week low for Delcath Systems share?

Delcath Systems share touched a 52 week high of $18.23 and a 52 week low of $7.45. Delcath Systems stock price today, August 16, 2025 at 1:29 AM IST is trending at $10.34, lower by 43.28% versus the 52 week high.

How to invest in Delcath Systems Stock (DCTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Delcath Systems on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Delcath Systems Shares that will get you 0.1451 shares as per Delcath Systems share price of $10.34 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Delcath Systems Stock (DCTH) from India?

Indian investors can start investing in Delcath Systems (DCTH) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Delcath Systems stock (as per the Rupee-Dollar exchange rate as on August 16, 2025). Based on Delcath Systems share’s latest price of $10.34 as on August 16, 2025 at 1:29 AM IST, you will get 0.9671 shares of Delcath Systems. Learn more about fractional shares .

What are the returns that Delcath Systems has given to Indian investors in the last 5 years?

Delcath Systems stock has given -14.98% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?